Alistair J. Ramsay, Ph.D.
Professor of Medicine


Education

  • B.Sc. in Physiology (1978), The University of Otago, New Zealand

  • B.Sc. in Microbiology (1979), The University of Otago, New Zealand

  • Ph.D. in Microbiology (1986), The University of Otago, New Zealand

Appointments

1992

Research Fellow, John Curtin School of Medical Research, Australian National University

1996

Senior Research Fellow, John Curtin School of Medical Research, Australian National University

1999

Associate Professor in Immunology and Microbiology, University of Newcastle, Australia

2001

Professor of Medicine, LSU/Tulane Gene Therapy Consortium,
LSU Health Sciences Center, New Orleans, USA

Selected Societies / Memberships

1990

Australasian Society for Immunology (ASI)

1991

American Association of Immunologists (AAI)

1999

Society for Mucosal Immunology (SMI)

1999

Australian Society for Microbiology (ASM)

(back to top)

Selected Peer Reviewed Publications (1993 - Present)

  • Ramsay AJ, Ruby J and Ramshaw IA (1993).  A case for cytokines as effector molecules in the resolution of virus infection.  Immunology Today 14: 155-157.

  • Ramsay AJ and Kohonen-Corish M (1993).  Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA reactivity in vivo.  European Journal of Immunology  23: 3141-3145. 

  • Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei K, Kohler G and Kopf M  (1994).  The role of interleukin-6 in mucosal IgA responses in vivo.  Science 264: 561-563.  

  • Ramsay AJ, Ramshaw IA and Kopf M (1994). Enhancement of specific mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors.  In:  Vaccines 94,  Brown F, Chanock, R, Ginsberg, H and Norrby, E (eds).  Cold Spring Harbor Laboratory Press.  pp 35-39.

  • Ramsay AJ, Leong KH, Boyle D, Ruby J and Ramshaw IA (1994).  Enhancement of specific mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors. Reproduction, Fertil. And Devel. 6: 389-392. 

  • Leong KH, Ramsay AJ, Boyle DB and Ramshaw IA (1994).  Selective induction of immune responses by cytokines co-expressed in recombinant fowlpox virus.  Journal of Virology 68: 8125-8130. 

  • Ramsay AJ (1995). Vector-encoded interleukin-5 and interleukin-6 enhance specific mucosal immunoglobulin A reactivity in vivo.  Advances in Experimental Medicine and Biology 371A: 35-42.

  • Leong KH, Ramsay AJ, Morin, MJ, Robinson HL, Boyle DB and Ramshaw IA (1995).  Generation of enhanced immune responses by consecutive immunisation with DNA and recombinant fowlpox virus. In: Vaccines 95,  Brown F, Chanock R, Ginsberg H and Norrby E (eds). Cold Spring Harbor Laboratory Press. pp 327-331.

  • Ramsay AJ (1995).  Genetic approaches to the study of cytokine regulation of  mucosal immunity.  Immunology and Cell Biology 73: 484-488.

  • Foster PS, Hogan S, Ramsay AJ, Matthaei K & Young IG (1996).  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in a mouse asthma model.  Journal of Experimental Med. 183: 195-201.

  • Ramsay AJ, Bao S, Beagley KW, Dunstan SJ, Husband AJ, Kopf M, Matthaei KI, Ramshaw IA, Strugnell RA, Young IG and Tan X (1996). Cytokine Gene Knockout Mice - Lessons for Mucosal B Cell Development.  In: Essentials of Mucosal Immunology, Kagnoff M and Kiyono H (eds).  Academic Press.  San Diego. pp 247-261.

  • Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Millbourne EA, Dai WJ, Ovington KS, Behm CA, Kohler G, Young IG and Matthaei KI (1996). IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4: 15-24.

  • Sharma DP, Ramsay AJ, Maguire DJ, Rolph MS and Ramshaw IA (1996). Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo.  Journal of Virology 70: 7103-7107. 

  • Husband AJ, Bao S, McClure SJ, Emery DL and Ramsay AJ (1996).  Antigen delivery strategies for mucosal vaccines.  International Journal of Parasitology 26: 825-834. 

  • Ada GL and Ramsay AJ (1997).  Vaccines, Vaccination and the Immune Response. Raven Lippincott.  Philadelphia. 247 pages. ISBN 0-397-58761-9.

  • Ramsay AJ, Leong KH and Ramshaw IA (1997).  DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunisation with DNA and viral vectors.  Immunology and Cell Biology 75: 382-388. 

  • Ramshaw IA, Ramsay AJ, Karupiah G, Rolph MS, Mahaligam S and Ruby JC (1997). Cytokines and immunity to viral infections.  Immunological Reviews 159: 119-135. 

  • Simeonovic CJ, Townsend MJ, Wilson JD, McKenzie KUS, Ramsay AJ, Matthaei KI, Mann DA and Young IG (1997).  Eosinophils are not required for the rejection of neovascularised fetal pig proislet xenografts in mice.  Journal of Immunology 158: 2490-2499.   

  • Leong KH, Ramshaw IA and Ramsay AJ (1997).  Interleukin-7 enhances cell-mediated immune responses in vivo in an IL-2-dependent manner.  Viral Immunology 10: 1-9.

  • Hogan SP, Mould A, Kikutani H, Ramsay AJ and Foster PS (1997).  Aeroallergen-induced eosinophilic inflammation, lung damage and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins.  Journal of Clinical Investigation 99: 1329-1339. 

  • Hogan SP, Foster PS, Tan X and Ramsay AJ (1998).  Mucosal interleukin-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity.  European Journal of Immunology 28: 413-423. 

  • Estcourt MJ, Ramshaw IA and Ramsay AJ (1998).  Cytokine responses in virus infections:  effects on pathogenesis, recovery and persistence.  Current Opinion in Microbiology  1: 411-418.    

  • Hogan SP, Mould AW, Young JM, Rothenberg ME, Ramsay AJ, Matthaei K, Young IG and Foster PS (1998).  Cellular and molecular regulation of eosinophil trafficking to the lung.  Immunology and Cell Biology 76: 454-460. 

  • Xiong Y, Karupiah G, Hogan SP, Foster PS and Ramsay AJ  (1999). Inhibition of allergic airways inflammation in mice lacking nitric oxide synthase 2.  Journal of Immunology  162: 445-452. 

  • Ramsay AJ and Beagley KW (1999). Development of B Lymphocytes within the Mucosal Immune System. In: Development of the Gastrointestinal Tract. Sanderson IR, Walker W Allan (eds). ). BC Decker. Ontario.  pp 175-196. 

  • Ramsay AJ, Kent SJ, Strugnell RA, Suhrbier A, Thomson SA and Ramshaw IA (1999).  Genetic Vaccination Strategies for Enhanced Cellular, Humoral and Mucosal Immunity. Immunological Reviews 171:  27-44.   

  • Cheers C, Janas M, Ramsay A, Ramshaw I (1999). Use of recombinant viruses to deliver cytokines influencing the course of experimental bacterial infection. Immunology and Cell Biology  77: 324-330.   

  • Ramsay AJ, Hogan SP, Foster PS and Xiong Y. (2000). Cytokine Gene Therapy of Allergic Airways Inflammation.  In: Gene Therapy in Inflammatory Diseases. Evans CH & Robbins PD (eds). Progr. in Inflam Res. Birkhauser. Basel.

  • Mould AW, Ramsay AJ, Matthaei KI, Young IG, Rothenberg ME and Foster PS. (2000).  The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity.  Journal of Immunology 164: 2142-2150.

  •  Ramshaw IA and Ramsay AJ. (2000). The prime-boost approach – exciting prospects for improved vaccination. Immunology Today  21: 160-162.  

  • Braciak TA, Gallichan WS, Graham FL, Richards CD, Ramsay AJ, Rosenthal KL and Gauldie J.  (2000).  Recombinant adenovirus vectors expressing interleukin-5 and –6 specifically enhance mucosal immunoglobulin A responses in the lung. Immunology 11: 388-396. 

  • Lees CJ, Apostolopoulos V, Acres B, Ramshaw I, Ramsay AJ, Popovski V, Ong CS and McKenzie IFC (2000).  Immunotherapy using M-FP and IL-12 in MUC-1 transgenic mice.  Vaccine 19: 158-162. 

  • Banyer J, Hamilton N, Ramshaw IA and Ramsay AJ. (2000). Cytokines in innate and adaptive immunity.  Reviews in Immunogenetics 2: 359-373.

  •  Jackson RJ, Ramsay AJ, Christensen CD, Beaton S, Hall DF and Ramshaw IA.  (2001).  Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.  Journal of Virology 75: 1205-1210.

  • Stevceva L, Pavli P, Husband A, Ramsay AJ and Doe WF. (2001). Dextran sulphate sodium-induced colitis is ameliorated in interleukin 4 deficient mice. Genes and Immunity, in press.

  • Estcourt MJ, Ramsay AJ, Brooks A, Thomson SA, Medveczky CJ and Ramshaw IA. (2001). Prime-boost immunization generates a high avidity CD8+ CTL population.  International Immunology, in press.

(back to top)